Risks

Net debt to EBITDA of 3.0x and interest coverage of 1.5x leave ASTH more exposed to refinancing and rate pressure than lower-levered peers, constraining flexibility.

Current ratio of 1.23x provides only modest liquidity headroom, so any claims volatility or working-capital swing could pressure near-term execution more than for stronger-balance-sheet peers.

Days sales outstanding of 46.8 and a 21-day cash conversion cycle indicate slower cash realization than leaner operators, which can dilute free-cash-flow conversion versus peers.

Debt-to-equity of 1.18x suggests a meaningfully levered capital structure, so earnings volatility would transmit more directly to equity value than at less levered peers.

Opportunities

ASTH’s moderate leverage can still support growth if underwriting and claims trends remain stable, and its balance sheet is not as stretched as highly levered peers.

A 21-day cash conversion cycle is reasonably efficient for an insurance model, supporting working-capital discipline versus peers with slower premium collection and settlement timing.

The absence of inventory and a current ratio above 1.2x reduce operational cash drag, giving ASTH more liquidity resilience than asset-heavy or working-capital-intensive peers.

If interest coverage improves from 1.5x, incremental earnings can translate more cleanly into equity value than for peers already burdened by heavier debt service.

Overall Score

ASTH’s forward positioning is constrained by elevated leverage and thin interest coverage versus peers, while moderate liquidity and efficient cash conversion provide some offsetting resilience.